WallStreetZenWallStreetZen

NASDAQ: VCYT
Veracyte Inc Stock Ownership - Who owns Veracyte?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Veracyte Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Marc StapleyChief Executive Officer2026-06-04138,051$50.12
$6.92MSell
Marc StapleyChief Executive Officer2026-06-04138,051$36.60
$5.05MBuy
Annie McGuireEVP General Counsel2026-06-041,400$49.31
$69.03kSell
Rebecca ChambersChief Financial Officer2026-06-041,600$49.28
$78.85kSell
Rebecca ChambersChief Financial Officer2026-06-041,961$50.09
$98.23kSell
Annie McGuireEVP General Counsel2026-06-041,776$50.12
$89.01kSell
John LeiteGlobal Chief Commercial Off2026-06-0413,975$50.07
$699.73kSell
Rebecca ChambersChief Financial Officer2026-06-023,693$47.80
$176.53kSell
John LeiteGlobal Chief Commercial Off2026-06-024,059$47.80
$194.02kSell
Jonathan WygantVP Chief Accounting Officer2026-06-021,361$47.80
$65.06kSell

1 of 9

VCYT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VCYT insiders and whales buy or sell their stock.

VCYT Shareholders

What type of owners hold Veracyte Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc16.51%13,172,618$670.75MInstitution
Fmr LLC9.73%7,763,849$395.34MInstitution
Artisan Partners Limited Partnership6.89%5,496,370$279.88MInstitution
State Street Corp6.32%5,043,590$256.82MInstitution
Vanguard Portfolio Management LLC5.57%4,444,730$226.33MInstitution
Brian G. Atwood4.53%3,616,221$184.14MInsider
Samuel D. Colella4.53%3,616,221$184.14MInsider
Versant Ventures III LLC4.53%3,616,221$184.14MInsider
Brook H. Byers4.45%3,551,929$180.86MInsider
Tpg Group Holdings Sbs Advisors Inc4.45%3,551,929$180.86MInsider

1 of 3

VCYT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VCYT67.24%32.76%Net SellingNet Selling
KNSA59.03%10.53%Net SellingNet Selling
ORKA25.55%74.45%Net BuyingNet Selling
CELC80.59%19.41%Net BuyingNet Selling
CPRX84.22%15.78%Net Buying
View Top Biotech Stocks

Veracyte Stock Ownership FAQ

Who owns Veracyte?

Veracyte (NASDAQ: VCYT) is owned by 110.64% institutional shareholders, 53.90% Veracyte insiders, and 0.00% retail investors. Brian G. Atwood is the largest individual Veracyte shareholder, owning 3.62M shares representing 4.53% of the company. Brian G. Atwood's Veracyte shares are currently valued at $185.48M.

If you're new to stock investing, here's how to buy Veracyte stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.